• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经前后不同的宫颈微生物群和代谢物谱:对宫颈癌进展的影响。

Distinct cervical microbiome and metabolite profiles before and after menopause: implications for cervical cancer progression.

作者信息

Kawasaki Rie, Kukimoto Iwao, Nishio Eiji, Otani Sayaka, Nishizawa Haruki, Maeda Yasuhiro, Iwata Aya, Fujii Takuma

机构信息

Department of Gynecology, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.

Department of Obstetrics and Gynecology, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.

出版信息

Front Cell Infect Microbiol. 2025 Jul 16;15:1589277. doi: 10.3389/fcimb.2025.1589277. eCollection 2025.

DOI:10.3389/fcimb.2025.1589277
PMID:40740347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12307382/
Abstract

INTRODUCTION

Cervical cancer is the fourth most common malignancy in women and is primarily caused by persistent infection with high-risk human papillomavirus (HPV). In addition, host immune responses, genetic factors, and lifestyle habits also have etiological roles. The cervicovaginal microbiome undergoes dynamic changes during menopause, which may be involved in the progression of cervical neoplasia. We aimed to elucidate the association between cervical microenvironmental changes and the progression of cervical neoplasia before and after menopause by integrating analyses of the cervical microbiome, related metabolites, cytokines, and microRNAs.

METHODS

A total of 248 HPV-positive women with cervical neoplasia, including 17 with cervical intraepithelial neoplasia (CIN1), 80 with CIN2, 82 with CIN3, and 69 with squamous cell carcinoma (SCC), were enrolled. As normal controls, 48 HPV-negative healthy women were included. Each group was stratified based on the mean menopausal age of 50 years. Cervical mucus was analyzed according to the methods outlined below. The microbiota was profiled by 16S rRNA gene sequencing, metabolites were analyzed by ultra-HPLC-tandem mass spectrometry, RT-qPCR was used for miRNA expression analysis, and RANTES levels were quantified by multiplex bead array. Data analysis was performed using MicrobiomeAnalyst and MetaboAnalyst.

RESULTS

In the SCC group, and were the key bacterial genera among the younger group, while , , and were more prevalent in elderly group (LDA score > 4.5). We observed a consistent positive correlation between and xanthine in younger groups with CIN2 or worse ( < 0.0001). However, no such correlations were detected in elderly women. In addition, , , and showed significant positive correlation with nicotinic acid in younger women with SCC compared to the elderly women ( < 0.0001). In the younger SCC women, several metabolites were significantly elevated in groups with high expression levels of RANTES, miR-20b-5p, and miR-155-5p.

CONCLUSION

The cervical microbiome undergoes changes during menopause, and may influence disease progression by interacting with metabolites, cytokines, and miRNAs. These results highlight the potential for personalized medicine for cervical cancer that is tailored to different age groups.

摘要

引言

宫颈癌是女性中第四常见的恶性肿瘤,主要由高危型人乳头瘤病毒(HPV)持续感染引起。此外,宿主免疫反应、遗传因素和生活习惯也具有病因学作用。宫颈阴道微生物群在绝经期间会发生动态变化,这可能与宫颈肿瘤的进展有关。我们旨在通过整合宫颈微生物群、相关代谢物、细胞因子和微小RNA的分析,阐明绝经前后宫颈微环境变化与宫颈肿瘤进展之间的关联。

方法

共纳入248例HPV阳性的宫颈肿瘤女性,其中17例为宫颈上皮内瘤变(CIN1),80例为CIN2,82例为CIN3,69例为鳞状细胞癌(SCC)。作为正常对照,纳入48例HPV阴性的健康女性。每组根据平均绝经年龄50岁进行分层。按照以下所述方法对宫颈黏液进行分析。通过16S rRNA基因测序对微生物群进行分析,通过超高效液相色谱-串联质谱法分析代谢物,使用RT-qPCR进行miRNA表达分析,并通过多重微珠阵列对RANTES水平进行定量。使用MicrobiomeAnalyst和MetaboAnalyst进行数据分析。

结果

在SCC组中,年轻组的关键细菌属为 和 ,而老年组中 、 和 更为普遍(线性判别分析得分>4.5)。我们在CIN2或更严重病变的年轻组中观察到 和黄嘌呤之间存在一致的正相关(<0.0001)。然而,在老年女性中未检测到此类相关性。此外,与老年女性相比,年轻SCC女性中 、 和 与烟酸呈显著正相关(<0.0001)。在年轻的SCC女性中,RANTES、miR-20b-5p和miR-155-5p高表达组中的几种代谢物显著升高。

结论

宫颈微生物群在绝经期间会发生变化,并可能通过与代谢物、细胞因子和miRNA相互作用影响疾病进展。这些结果凸显了针对不同年龄组的宫颈癌个性化医疗的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6159/12307382/9670cae4f113/fcimb-15-1589277-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6159/12307382/29ecebb8164c/fcimb-15-1589277-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6159/12307382/4f91d0a3b961/fcimb-15-1589277-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6159/12307382/c733f5a6a750/fcimb-15-1589277-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6159/12307382/5d77ab2b3516/fcimb-15-1589277-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6159/12307382/7bbf973c034a/fcimb-15-1589277-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6159/12307382/620cf9ec62f9/fcimb-15-1589277-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6159/12307382/9670cae4f113/fcimb-15-1589277-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6159/12307382/29ecebb8164c/fcimb-15-1589277-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6159/12307382/4f91d0a3b961/fcimb-15-1589277-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6159/12307382/c733f5a6a750/fcimb-15-1589277-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6159/12307382/5d77ab2b3516/fcimb-15-1589277-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6159/12307382/7bbf973c034a/fcimb-15-1589277-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6159/12307382/620cf9ec62f9/fcimb-15-1589277-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6159/12307382/9670cae4f113/fcimb-15-1589277-g007.jpg

相似文献

1
Distinct cervical microbiome and metabolite profiles before and after menopause: implications for cervical cancer progression.绝经前后不同的宫颈微生物群和代谢物谱:对宫颈癌进展的影响。
Front Cell Infect Microbiol. 2025 Jul 16;15:1589277. doi: 10.3389/fcimb.2025.1589277. eCollection 2025.
2
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.接种人乳头瘤病毒预防性疫苗以预防宫颈癌及其癌前病变。
Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3.
3
Microbiome and metabolomic changes associated with HPV clearance in women undergoing local excisional treatment for cervical intraepithelial neoplasia.接受宫颈上皮内瘤变局部切除治疗的女性中与HPV清除相关的微生物组和代谢组变化。
mSystems. 2025 Jun 17;10(6):e0051125. doi: 10.1128/msystems.00511-25. Epub 2025 May 20.
4
Integrated analysis of microbiome and metabolome reveals insights into cervical neoplasia aggravation in a Chinese cohort.微生物组和代谢组的综合分析揭示了中国队列中宫颈肿瘤恶化的相关见解。
Front Cell Infect Microbiol. 2025 May 8;15:1556153. doi: 10.3389/fcimb.2025.1556153. eCollection 2025.
5
Inferred bi-directional interactions between vaginal microbiota, metabolome and persistent HPV infection accompanied by high-grade cervical intraepithelial neoplasia.阴道微生物群、代谢组与伴有高级别宫颈上皮内瘤变的持续性人乳头瘤病毒感染之间的推断性双向相互作用。
BMC Microbiol. 2025 Jul 2;25(1):404. doi: 10.1186/s12866-025-04126-w.
6
[Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].[卫生技术评估报告。液基细胞学在宫颈癌前病变筛查中的应用]
Epidemiol Prev. 2012 Sep-Oct;36(5 Suppl 2):e1-e33.
7
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.人乳头瘤病毒检测与重复细胞学检查用于轻度宫颈细胞学病变的分流
Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD008054. doi: 10.1002/14651858.CD008054.pub2.
8
Alterations in vaginal microbiome in women with short cervix: longitudinal study of microbial diversity and impact of vaginal progesterone treatment.宫颈短的女性阴道微生物群的改变:微生物多样性的纵向研究及阴道孕酮治疗的影响
Ultrasound Obstet Gynecol. 2025 Jun 26. doi: 10.1002/uog.29269.
9
Cervicovaginal microbiota disorder combined with the change of cytosine phosphate guanine motif- toll like receptor 9 axis was associated with cervical cancerization.宫颈阴道微生物群失调与胞嘧啶磷酸鸟嘌呤基序- toll 样受体 9 轴的改变与宫颈癌化有关。
J Cancer Res Clin Oncol. 2023 Dec;149(19):17371-17381. doi: 10.1007/s00432-023-05453-z. Epub 2023 Oct 16.
10
The Utility of an Human Papillomavirus Genotype Assay for Cancer Screening in Self-Collected Urine and Vaginal Samples from Japanese Women.人乳头瘤病毒基因分型检测在日本女性自行采集的尿液和阴道样本癌症筛查中的效用
Gynecol Obstet Invest. 2025;90(2):143-152. doi: 10.1159/000541641. Epub 2024 Oct 7.

本文引用的文献

1
Recent advances in HPV biotechnology: understanding host-virus interactions and cancer progression - a review.人乳头瘤病毒生物技术的最新进展:了解宿主 - 病毒相互作用与癌症进展——综述
Int J Surg. 2024 Dec 1;110(12):8025-8036. doi: 10.1097/JS9.0000000000002117.
2
Understanding the role of miRNAs in cervical cancer pathogenesis and therapeutic responses.了解微小RNA在宫颈癌发病机制及治疗反应中的作用。
Front Cell Dev Biol. 2024 Aug 28;12:1397945. doi: 10.3389/fcell.2024.1397945. eCollection 2024.
3
Cervical mucus can be used for metabolite screening in cervical cancer.
宫颈黏液可用于宫颈癌的代谢物筛查。
Cancer Sci. 2024 Nov;115(11):3672-3681. doi: 10.1111/cas.16323. Epub 2024 Aug 22.
4
Cervicovaginal microbiome, high-risk HPV infection and cervical cancer: Mechanisms and therapeutic potential.宫颈阴道微生物组、高危型 HPV 感染与宫颈癌:机制与治疗潜力。
Microbiol Res. 2024 Oct;287:127857. doi: 10.1016/j.micres.2024.127857. Epub 2024 Jul 26.
5
Emerging paradigms: unmasking the role of oxidative stress in HPV-induced carcinogenesis.新兴范式:揭示氧化应激在人乳头瘤病毒诱导的致癌作用中的角色
Infect Agent Cancer. 2024 Jul 2;19(1):30. doi: 10.1186/s13027-024-00581-8.
6
Risk factors for the development of cervical cancer: analysis of the evidence.宫颈癌发生的危险因素:证据分析
Front Oncol. 2024 May 23;14:1378549. doi: 10.3389/fonc.2024.1378549. eCollection 2024.
7
Performance of an ancillary test for cervical cancer that measures miRNAs and cytokines in serum and cervical mucus.用于测量血清和宫颈黏液中 microRNA 和细胞因子的宫颈癌辅助检测试验的性能。
Cancer Sci. 2024 Aug;115(8):2795-2807. doi: 10.1111/cas.16214. Epub 2024 May 15.
8
Microbiome and cancer: from mechanistic implications in disease progression and treatment to development of novel antitumoral strategies.微生物组与癌症:从疾病进展和治疗中的机制影响到新型抗肿瘤策略的开发。
Front Immunol. 2024 Apr 23;15:1373504. doi: 10.3389/fimmu.2024.1373504. eCollection 2024.
9
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
10
Molecular aspects of cervical cancer: a pathogenesis update.宫颈癌的分子学研究进展:发病机制的最新情况
Front Oncol. 2024 Mar 19;14:1356581. doi: 10.3389/fonc.2024.1356581. eCollection 2024.